Lead Pharma

We found Phares Consultancy a company providing outstanding services and innovative solutions in the field of  genetically altered in vivo models. Our project focused on cardiovascular diseases, and was supported under highly attractive conditions. With special attention for high quality service Phares set up well-defined research objectives that met commercial needs. In addition Phares provided a safe laboratory environment with strict and transparent (health) conditions.

Our project focused on defined sample collection to study biological expression profiles in heart failure linked to actual physsiological measurements. In addition Phares could provide import, housing and breeding of transgenic mouse lines and for heart failure studies. During the project we received monthly written updates summarizing the progress of the research and appropriate meetings were scheduled to discuss the progress and possible adjustments.

Jan Klomp

Lead Pharma